Creating certainty in a landscape still convulsed by the pandemic is a lofty ambition, but pharma companies can use the disruption to develop positive internal change, as well as shoring up
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
